Drug research has not significantly advanced in the past half-century, with most new drugs being variations of existing ones.

The Expose News - com

<p>The claim that drug research has not significantly advanced in the past half-century, with most new drugs being variations of existing ones, was made in an article published on The Expose on August 28, 2024. This claim is based on an essay by Dr. Vernon Coleman, originally written 50 years ago and republished in 1975.</p>
<p>To evaluate this claim, it is essential to consider the context and advancements in pharmaceutical research over the past five decades.</p>
<h2>Historical Context</h2>
<p>Dr. Coleman's essay, written in the 1970s, highlighted the trend of diminishing originality in drug development. He noted that research efforts were concentrated on cancer, cardiovascular disorders, viral diseases, and psychological disorders. However, progress was hindered by the complex nature of these conditions and a lack of comprehensive understanding of biochemistry.</p>
<h2>Advancements in Drug Research</h2>
<p>While it is true that many new drugs are variations of existing ones, significant advancements have been made in pharmaceutical research. For instance, the development of targeted therapies for cancer, such as monoclonal antibodies and kinase inhibitors, has revolutionized cancer treatment. These therapies are designed to specifically target cancer cells, reducing side effects and improving patient outcomes. A study published in the <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776980/">Journal of Clinical Oncology</a> highlights the impact of targeted therapies on cancer treatment.</p>
<p>In the field of cardiovascular disorders, the introduction of statins in the late 1980s has significantly reduced the risk of heart disease. Statins work by lowering cholesterol levels, which is a major risk factor for cardiovascular diseases. A review published in the <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967093/">Journal of the American College of Cardiology</a> discusses the efficacy and safety of statins.</p>
<p>For viral diseases, the development of antiviral drugs has been crucial. For example, the introduction of antiretroviral therapy (ART) for HIV has transformed the disease from a fatal condition to a manageable chronic illness. A study published in the <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843618/">Lancet</a> discusses the impact of ART on HIV treatment.</p>
<p>In the field of psychological disorders, the development of selective serotonin reuptake inhibitors (SSRIs) has been a significant advancement. SSRIs are a class of antidepressants that work by increasing the levels of serotonin in the brain. A review published in the <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172306/">Journal of Clinical Psychiatry</a> discusses the efficacy and safety of SSRIs.</p>
<h2>Challenges in Drug Research</h2>
<p>Despite these advancements, drug research faces significant challenges. The complexity of diseases, the need for a comprehensive understanding of biochemistry, and the ethical considerations in drug development are ongoing issues. Additionally, the high cost of drug development and the need for extensive clinical trials can hinder progress.</p>
<h2>Conclusion</h2>
<p>The claim that drug research has not significantly advanced in the past half-century is partially true but oversimplifies the complexities and advancements in pharmaceutical research. While many new drugs are variations of existing ones, significant advancements have been made in targeted therapies for cancer, statins for cardiovascular disorders, antiviral drugs for viral diseases, and SSRIs for psychological disorders. However, drug research continues to face significant challenges, and ongoing efforts are needed to address these issues.</p>

Claim Review: Drug Research Stagnation Over the Past Half-Century

<h2>Introduction</h2>
<p>Remdesivir, an antiviral drug, has been widely promoted as a treatment for COVID-19 patients. However, the effectiveness and safety of this drug have been subjects of debate. This article aims to review the claim that Remdesivir is an effective treatment for COVID-19 patients and to provide a thorough analysis based on scientific evidence.</p>
<h2>What is Remdesivir?</h2>
<p>Remdesivir is a broad-spectrum antiviral drug that inhibits RNA polymerase, disrupting the production of vital RNA. It was initially developed to treat Ebola but has been repurposed for COVID-19 treatment.</p>
<h2>Claim Analysis</h2>
<p>The claim that Remdesivir is an effective treatment for COVID-19 patients is based on its approval by regulatory bodies such as the FDA, EU, and UK's drug regulator. However, several studies have cast doubt on its efficacy and safety.</p>
<h2>Scientific Evidence</h2>
<p>The World Health Organization's Solidarity Trial found that Remdesivir does not reduce mortality or the time COVID-19 patients take to recover. A study published in <a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31022-9/fulltext">The Lancet</a> also found no statistically significant benefit from the treatment.</p>
<p>Furthermore, a review of Remdesivir on <a href="https://www.drugs.com/comments/remdesivir/">drugs.com</a> showed that 47% of reviewers had a negative experience with the drug, compared to 19.38% who had a positive experience.</p>
<h2>Side Effects and Safety Concerns</h2>
<p>Remdesivir has been associated with several side effects, including fast, pounding heartbeats, trouble breathing, wheezing, shivering, itching, sweating, facial swelling, severe headache, and a feeling of being about to pass out. Subsequent side effects may include nausea and abnormal liver function tests.</p>
<p>The UK's National Institute for Health and Care Excellence (NICE) reports that Remdesivir interacts with twelve other drugs, including chloroquine, hydroxychloroquine, and phenytoin. Doctors prescribing Remdesivir should be aware of these interactions to avoid potential harm to patients.</p>
<h2>Conclusion</h2>
<p>Based on the available scientific evidence, the claim that Remdesivir is an effective treatment for COVID-19 patients is not supported. The drug has shown minimal efficacy in clinical trials and is associated with significant side effects. It is crucial for healthcare providers to consider the risks and benefits carefully before prescribing Remdesivir to COVID-19 patients.</p>

Claim Review: Remdesivir as an Effective Treatment for COVID-19

<h2>Introduction</h2>
<p>The claim that the Canadian government contract with Pfizer acknowledged the unknown long-term efficacy and safety of COVID-19 vaccines has been circulating widely. This article aims to review this claim, providing a thorough analysis and context based on reliable scientific sources.</p>
<h2>The Claim</h2>
<p>The claim states that the contract between the Canadian government and Pfizer, dated October 26, 2020, includes a section acknowledging that the long-term effects, efficacy, and adverse effects of the vaccine were not known at the time of signing. This information was reported by The Expose and The Canadian Independent.</p>
<h2>Analysis</h2>
<p>The contract indeed contains a section (5.5) under 'Purchaser Acknowledgement' that states: 'Purchaser further acknowledges that the long-term effects and efficacy of the Vaccine are not currently known and that there may be adverse effects of the Vaccine that are not currently known.' This acknowledgment is standard in contracts for new medical products, reflecting the ongoing nature of scientific research and the need for continuous monitoring.</p>
<p>It is important to note that the acknowledgment of unknown long-term effects does not imply that the vaccines are unsafe. Vaccines undergo rigorous testing and approval processes by regulatory bodies such as Health Canada and the U.S. Food and Drug Administration (FDA). These processes ensure that vaccines meet high safety and efficacy standards before they are administered to the public.</p>
<p>Furthermore, ongoing monitoring and research are essential for understanding the long-term effects of any new medical intervention. This is a standard practice in the medical field and is not unique to COVID-19 vaccines.</p>
<h2>Scientific Evidence</h2>
<p>Several peer-reviewed studies and reports from reliable scientific sources support the safety and efficacy of COVID-19 vaccines. For example, a study published in <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2101765">The New England Journal of Medicine</a> found that the Pfizer-BioNTech COVID-19 vaccine was highly effective in preventing symptomatic COVID-19 infections. Another study published in <a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00947-8/fulltext">The Lancet</a> reported similar findings for the Moderna vaccine.</p>
<p>These studies, along with ongoing surveillance by health authorities, provide evidence that COVID-19 vaccines are safe and effective in the short term. Long-term data is being continuously collected and analyzed to ensure the safety and efficacy of these vaccines over time.</p>
<h2>Conclusion</h2>
<p>The claim that the Canadian government contract with Pfizer acknowledged the unknown long-term efficacy and safety of COVID-19 vaccines is accurate. However, this acknowledgment is a standard practice in contracts for new medical products and does not imply that the vaccines are unsafe. Ongoing research and monitoring are essential for understanding the long-term effects of any new medical intervention. The available scientific evidence supports the safety and efficacy of COVID-19 vaccines in the short term, and long-term data is being continuously collected and analyzed.</p>

Claim Review: Canadian Government Contract with Pfizer on COVID-19 Vaccine Safety

<p>The claim that Food Standards in Australia and New Zealand are being changed to replace real food with fake 'food' without proper labelling or regulation has been circulating recently. This claim suggests that gene-edited foods will be deregulated, allowing the food industry to self-regulate and avoid labelling requirements. Let's break down this claim and examine its validity.</p>
<h2>Understanding the Claim</h2>
<p>The claim revolves around proposed changes to the Food Standards Code by FSANZ (Food Standards Australia New Zealand). These changes aim to deregulate gene-edited foods, which are created using techniques like CRISPR. The concern is that this deregulation would allow the food industry to avoid labelling and regulation, potentially misleading consumers.</p>
<h2>What is Gene Editing?</h2>
<p>Gene editing involves altering the DNA of an organism using techniques like CRISPR. This technology has the potential to create foods with desirable traits, such as improved nutritional content or resistance to diseases. However, the long-term effects of consuming gene-edited foods are not yet fully understood.</p>
<h2>Regulatory Changes and Concerns</h2>
<p>The proposed changes by FSANZ would exempt gene-edited foods from certain regulations, potentially allowing them to enter the market without thorough safety assessments or labelling. This has raised concerns among consumers and advocacy groups, who argue that consumers have the right to know what they are eating.</p>
<h2>Scientific Perspectives</h2>
<p>While gene editing holds promise for improving food production, there are valid concerns about its safety and long-term effects. A study published in <a href="https://www.nature.com/articles/s41586-018-0450-7">Nature</a> highlights the potential risks associated with CRISPR-edited organisms, including unintended genetic changes. Another study in <a href="https://www.sciencedirect.com/science/article/pii/S0160412019308477">Environment International</a> discusses the need for comprehensive risk assessment and regulation of gene-edited foods.</p>
<h2>Consumer Rights and Transparency</h2>
<p>The claim emphasizes the importance of consumer rights and transparency in food labelling. Consumers have the right to make informed choices about the food they consume. Deregulation without proper labelling could undermine this right and erode consumer trust in the food industry.</p>
<h2>Conclusion</h2>
<p>The claim that food standards are being changed to replace real food with fake 'food' without proper labelling or regulation is partially true. While there are proposed changes to deregulate gene-edited foods, the extent to which this will impact consumer safety and transparency is a matter of ongoing debate. It is crucial for regulatory bodies to balance innovation with consumer protection and ensure that any changes are based on sound scientific evidence and public consultation.</p>

Claim Review: Changes to Food Standards in Australia and New Zealand

If you want to replace an existing title on a portal and you want the replaced title to be visible to you and your followers.

Move the mouse over the title and make a right click.

Select Remedia -> Alternate Title from the menu

In the pop-up window, enter a new title that you like.

The blue icon copies the existing title into the input field, so you don't have to type everything...

By pressing Submit, the title will be replaced, which will be visible to you and others who visit the pages.

(There is a possibility that you will have to reload the page for the changes to be visible)

You can contact one of the fact-checking organizations.

Claim rated as -> Choose from false to true

Add claimer -> Opens a pop-up window that allows you to search for existing people already registered in the system or to create a new profile of that person.

Claimed At -> Enter the link to the page where the claim was found. You can add more places and link more claim authors

Short description -> short content that is seen when sharing articles on social networks

Field for entering the content of the article.

After the article is published, it will be visible on the Remedia social network and to everyone who has the Remedia Chrome extension installed

And you can engage in debunking yourself.

CAUTION! Abusing the platform is not allowed, entering unverified, misleading or untrue content will result in the deletion of the entire account with all content

Canonical -> If you enter content that already exists somewhere (your property), you can enter a link and Remedia will try to enter the content in the provided fields.

Featured image -> Image that is displayed when you share an article on other social networks.

Write your title -> Enter the title of the article

The claim being reviewed -> Enter the claim here, but BEWARE! An assertion is not the entire statement someone has made, but something concise and unambiguous. Check the claim entry multiple times as each change will create a new claim in the system.

Claim made on -> date when someone published the claim.

After installing the Chrome extension, you can log in and use advanced functionalities. One of them is 'Dislike'.

By right-clicking on an article, the options provided by the Remedia extension are opened, by selecting Dislike, the article will become more transparent and less visible.

Your action will be visible to you and all people who follow you!

Alternate Title

1. Log in to the Remedia social network with a Google or Facebook account (link above right).

2. Install the Chrome extension (if you didn't)

4. Enter the email you used to open your Google or Facebook account. Submit.

5. After the input field appears, rewrite the code. Accept.

That's it! Now you can use the advanced functions of the Remedia Chrome extension.

Alternate Titles

Remedia's work so far:

Remedia, the best thing that happened to media!

On the Feed page, you can enter Status, Opinion and Claim Review

It is enough to enter the title, short description and content.

Below the fields for entering content, you will find fields for entering links. By entering page links in these fields, you 'show' the Chrome extension on which pages to display your content

Press Publish to publish your opinion. (It may be necessary to wait a moment while all links are generated)

Claim: "Drug research has not significantly advanced in the past half-century, with most new drugs being variations of existing ones." is Half True

Has beed claimed by:

Articles reviewing this claim:

Content you might like: